Loretta J. Feehan
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
NL Upgraded to Outperform on CompX Strength, Kronos Recovery. The rating upgrade reflects a more positive outlook after CompX's strong performance and Kronos's recovery. NL is near its 52‑week low but sits above the $5.65 support level, and the RSI of 59.5 indicates a moderate trend.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Kronos Worldwide Shares Up 72% Year-to-Date. Kronos Worldwide stock has risen 72% since the start of the year, outperforming many peers in the basic materials sector. This significant gain places the stock near the upper end of its 52-week range, despite a current RSI of 35.4 suggesting recent cooling in momentum. The company also offers a high dividend yield of 8.93%.
Transaction History
| VHI | ▲ Buy | Grant | 3,150 | $40K | 5/21/2026 | View on chart |
| CIX | ▲ Buy | Grant | 1,700 | $40K | 5/20/2026 | View on chart |
| NL | ▲ Buy | Grant | 6,000 | $40K | 5/14/2026 | View on chart |
| KRO | ▲ Buy | Grant | 5,550 | $40K | 5/13/2026 | View on chart |
| VHI | ▲ Buy | Grant | 1,250 | $20K | 5/22/2025 | View on chart |
| CIX | ▲ Buy | Grant | 750 | $19K | 5/21/2025 | View on chart |
| NL | ▲ Buy | Grant | 2,500 | $20K | 5/15/2025 | View on chart |
| KRO | ▲ Buy | Grant | 2,800 | $20K | 5/14/2025 | View on chart |
| CIX | ▼ Sell | Gift | 700 | $0 | 11/18/2024 | View on chart |
| VHI | ▲ Buy | Grant | 1,050 | — | 5/23/2024 | View on chart |
| CIX | ▲ Buy | Grant | 800 | — | 5/22/2024 | View on chart |
| NL | ▲ Buy | Grant | 2,850 | — | 5/16/2024 | View on chart |
| KRO | ▲ Buy | Grant | 1,550 | — | 5/15/2024 | View on chart |
| VHI | ▲ Buy | Grant | 1,500 | — | 5/25/2023 | View on chart |
| CIX | ▲ Buy | Grant | 1,100 | — | 5/24/2023 | View on chart |
| NL | ▲ Buy | Grant | 3,550 | — | 5/18/2023 | View on chart |
| KRO | ▲ Buy | Grant | 2,450 | — | 5/17/2023 | View on chart |
| VHI | ▲ Buy | Grant | 400 | — | 5/26/2022 | View on chart |
| CIX | ▲ Buy | Grant | 900 | — | 5/25/2022 | View on chart |
| NL | ▲ Buy | Grant | 2,500 | — | 5/19/2022 | View on chart |
| KRO | ▲ Buy | Grant | 1,200 | — | 5/18/2022 | View on chart |
| NL | ▲ Buy | Grant | 2,750 | — | 5/20/2021 | View on chart |
| NL | ▲ Buy | Grant | 6,650 | — | 5/21/2020 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
NL Upgrades CompX to Outperform Citing Strength
New Lake upgraded CompX International to Outperform, citing the company's recent performance. This analyst action provides positive external validation for the stock. The move occurs while the share price remains within its 52-week range, offering a neutral technical backdrop for the news.
NL Upgrades CompX to Outperform Citing Strength. New Lake upgraded CompX International to Outperform, citing the company's recent performance. This analyst action provides positive external validation for the stock. The move occurs while the share price remains within its 52-week range, offering a neutral technical backdrop for the news.